Histologic, immunohistochemical, and ultrastructural findings in a case of minocycline-associated “black thyroid”
Tóm tắt
We report on a 37-yr-old woman with known antemortem ingestion of minocyclin who died suddenly from a ruptured cerebral aneurysm. At autopsy, her thyroid gland, although not enlarged, was diffusely black, caused by the deposition of a melanin-like pigment that stained positive with Schmorl’s reagent. The pigment could be bleached with permanganate, and on examination by electron microscopy, it appeared to be deposited within the thyrocyte lysosomes. Additional immunostaining with many antibodies revealed an increase in vimentin staining in the follicular epithelium compared with normal control thyroid glands. Staining for cytoplasmic thyroglobulin was markedly reduced, despite normal thyroid indices performed on stored antemortem blood. Stainable ubiquitin in the follicular epithelium appeared reduced compared with control thyroid tissues. These immunohistochemical findings may reflect disruptions of lysosomal transport and function associated with the abnormal accumulation of pigment. This appears to be the only case of minocyclin-associated “black thyroid” in which extensive immunohistochemical investigations have been performed.
Tài liệu tham khảo
Attwood HD, Dennett X. A black thyroid and minocycline treatment. Br Med J 2:1109–1110, 1976.
Alexander CB, Herrera GA, Jaffe K, Yu H. Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 16:72–78, 1985.
Onyia JN, Forrest LA, Forsthoefel K. Papillary carcinoma associated with black thyroid gland. Am J Otolaryngol 17:299–302, 1996.
Thompson AD, Pasieka MD, Kneafsey P, DiFrancesco LM. Hypopigmentation of a papillary carcinoma arising in a black thyroid. Mod Pathol 12:1181–1185, 1999.
Benathan M, Lemarchand-Beraud T, Gautier A, Gardiol D. Abnormal iodoprotein distribution and resistance to proteolysis in Gunn rat black thyroid: an ultrastructural and biochemical study. Virchows Archiv B Cell Pathol Incl Mol Pathol 44:323–336, 1983.
Gordon G, Sparano BM, Kramer AW, Kelly RG, Iatropoulos MJ. Thyroid gland pigmentation and minocycline therapy. Am J Pathol 117:98–109, 1984.
Kurosumi M, Fujita H. Fine structural aspects of the black thyroid induced by minocycline, and the effects of a low iodine diet, propylthiouracil, thyroxine tablet and TSH, on the black discoloration of the rat thyroid. Virchows Archiv B Cell Pathol Incl Mol Pathol 48:219–227, 1985.
Taurog A, Dorris ML, Doerge DR. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid 6:211–219, 1996.
Carr NJ. M30 expression demonstrates apoptotic cells, correlates with in situ endlabelling, and is associated with Ki-67 expression in large intestinal neoplasms. Arch Pathol Lab Med 124:1768–1772, 2000.
Saul SH, Dekker A, Lee RE, Breitfeld V. The black thyroid: its relation to minocycline use in man. Arch Pathol Lab Med 107:173–177, 1983.
Reid JD. The black thyroid associated with minocycline therapy: a local manifestation of a drug-induced lysosome/substrate disorder. Am J Clin Pathol 79:738–746, 1983.
Landas SK, Schelper RL, Fermin OT, Turner JW, Moore KC, Bennett-Gray J. Black thyroid syndrome: exaggeration of a normal process? Am J Clin Pathol 85:411–418, 1986.
Mayer RJ, Gaskell MJ, Earl R, et al. Intracellular protein catabolism: evidence for sequestration of proteins into an intermediate-filament fraction before lysosomal degradation. Biomed Biochim Acta 45:1591–1602, 1986.
Ivleva TS, Tint IS, Bershadskii AD, Vidershain GI. Changes in the organization of the intermediate filament system of human fibroblasts in lysosomal storage diseases and their modeling. Biull Eksp Biol Med 113:263–268, 1992.
Gillard BK, Clement R, Colucci-Guyon E, et al. Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments. Exp Cell Res 242:561–572, 1998.
Traub P, Perides G, Kuhn S, Scherbarth A. Efficient interaction of nonpolar lipids with intermediate filaments of the vimentin type. Eur J Cell Biol 43:55–64, 1987.
Schweitzer SC, Evans RM, Vimentin and lipid metabolism. Subcell Biochem 31:437–462, 1998.
Alahbobi G, Williams LJ, Hall PF. Attachment of steroidogenic lipid droplets to intermediate filaments in adrenal cells. J Cell Sci 101:383–393, 1992.
Kotani M, Hosoya H, Kubo H, et al. Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts. Cell Struct Funct 19:81–87, 1994.
Perides G, Scherbarth A, Traub P. Influence of phospholipids on the formation and stability of vimentin-type intermediate filaments. Eur J Cell Biol 42:268–280, 1986.
Perides G, Scherbarth A, Kuhn S, Traub P. An electron microscopic study of the interaction in vitro of vimentin intermediate filaments with vesicles prepared from Erlich ascites tumor cell lipids. Eur J Cell Biol 41:313–325, 1986.
Mayer RJ, Lowe J, Lennox G, Doherty F, Landon M. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases. Prog Clin Biol Res 317:809–818, 1989.
Franke WW, Schmid E, Grund C, Geiger B. Intermediate filament proteins in nonfilamentous structures: transient disintegration and inclusion of subunit proteins in granular aggregates. Cell 30:103–113, 1982.
Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516–520, 1998.
Mayer RJ, Lowe J, Landon M, et al. Ubiquitin and the lysosome system; molecualr immunopathology reveals the connection. Biomed Biochim Acta 50:333–341, 1991.
DeSalle LM, Pagano M. Regulation of the GI to S transition by the ubiquitin pathway. FEBS Lett 490:179–189, 2001.
Hicke L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2:195–201, 2001.
Keegan BP, Sheflin LG, Spaulding SW. Thyrotropin regulates the levels of free ubiquitin and ubiquitin-protein conjugates in the male mouse thyroid. Thyroid 7:929–935, 1997.